Crossover Post-herpetic Neuralgia (PHN)

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

February 29, 2012

Study Completion Date

June 30, 2012

Conditions
Post-Herpetic Neuralgia (PHN)
Interventions
DRUG

BMS-954561

DRUG

BMS-954561

DRUG

Placebo

Trial Locations (23)

14618

Finger Lakes Clinical Research, Rochester

27103

Pmg Research Of Winston-Salem, Winston-Salem

27612

Wake Research Associates, Llc, Raleigh

30060

Drug Studies America, Marietta

32806

Compass Research, Llc, Orlando

33076

Local Institution, Bordeaux

33445

Brain Matters Research, Delray Beach

33716

Comprehensive Clinical Development, Inc., St. Petersburg

34471

Renstar Medical Research, Ocala

42277

Local Institution, Saint-Priest-en-Jarez

42431

Commonwealth Biomedical Research, Llc, Madisonville

44311

Radiant Research, Inc., Akron

48334

Quest Research Institute, Farmington Hills

63117

Medex Healthcare Research, Inc, St Louis

64114

The Center For Pharmaceutical Research. Pc, Kansas City

73103

Cor Clinical Research, Oklahoma City

78731

Futuresearch Trials Of Neurology, Austin

80304

Alpine Clinical Research Center, Boulder

85023

Arizona Research Center, Phoenix

90717

Torrance Clinical Research, Lomita

92100

Local Institution, Boulogne-Billancourt

01760

Analgesic Solutions, Natick

06003

Local Institution, Nice

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY